Groups convene in Washington, DC for third annual national medical cannabis conference March 27-31
The American Herbal Products Association (AHPA) Cannabis Committee, in coordination with Americans for Safe Access (ASA), and the Hemp Industries Association (HIA), has announced the release of a joint statement advocating for implementation of best practices for the regulation of consumable, topical, and inhalant cannabis and hemp-derived products to ensure quality and consumer safety.
These best practices were developed with the input of numerous industry experts and establish common language and defined terms for the transparent and accurate labeling of these products to support responsible commerce and informed use of the cannabis plant.
AHPA, ASA and HIA will be promoting these best practices at the 3rd Annual National Medical Cannabis Unity Conference being held March 27-31, in Washington, DC.
Recommendations for plant part identification
The AHPA Cannabis Committee has established a policy that lawfully-marketed products consisting of or including Cannabis spp. ingredients that are intended for oral ingestion, topical application, or inhalation be labeled to identify the part of the Cannabis plant from which the ingredient is derived (e.g., seed oil, flower extract, or extract of aerial parts). This policy does not apply to parts of the Cannabis plant provided to consumers in unprocessed and recognizable forms.